Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis Interventions: Drug: Infliximab; Drug: Infliximab; Drug: Infliximab Sponsors: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW; Celltrion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials